Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11584933
RNA interference in ocular indications
granted -
US 11583542
Compositions of bile acids and phenylbutyrate compounds
granted -
US 11583540
Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)
granted -
US 11584733
Selective histone deacetylase inhibitors for the treatment of human disease
granted -
US 11584923
Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same
granted -
US 11583530
Compounds for the prevention and treatment of medical disorders and uses thereof
granted -
US 11584736
Heterocyclic P2Y14 receptor antagonists
granted -
US 11583526
Treatment of prostate cancer
granted -
US 11584758
RIP1K inhibitors
granted -
US 11583578
Plasmodium falciparum recombinanr xiexumapoeozoite protein compositions and method for vaccine delivery
granted -
US 11584780
Adeno-associated virus capsid proteins
granted -
US 11576744
Thermosensitive bio-adhesive hydrogel for removal of ureteral and renal stones
granted -
US 11576951
Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
granted -
US 11576983
Treatments for retinal disease
granted -
US 11576863
Formulation of an antibody and use thereof
granted -
US 11578315
Truncated guinea pig L-asparaginase variants and methods of use
granted -
US 11579150
Methods for characterizing disulfide bonds
granted -
US 11576356
Genetically modified non-human animals and methods of use thereof
granted -
US 11576907
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
granted -
US 11578371
Biomarkers for predicting tumor response to and toxicity of immunotherapy
granted -
US 11578126
Chimeric antigen receptor (CAR) comprising a CD19-binding domain
granted -
US 11578127
Anti-Fc epsilon-R1 alpha (FcεR1α) antibodies, bispecific antigen-binding molecules that bind FcεR1α and CD3, and uses thereof
granted -
US 11578066
Fluoroalkyl-oxadiazoles and uses thereof
granted -
US 11578135
Multispecific antigen-binding molecules binding to a target and an internalizing effector protein that is CD63 and uses thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.